The nuclear factor kappa B p50 subunit and cortactin as markers to distinguish between keratoacanthoma and well-differentiated squamous cell carcinoma.

@article{Fujii2011TheNF,
  title={The nuclear factor kappa B p50 subunit and cortactin as markers to distinguish between keratoacanthoma and well-differentiated squamous cell carcinoma.},
  author={Mizue Fujii and Masaaki Honma and Hisaaki Takahashi and Akemi Ishida-Yamamoto and Hajime Iizuka},
  journal={Clinical and experimental dermatology},
  year={2011},
  volume={36 7},
  pages={
          788-92
        }
}
  • Mizue Fujii, Masaaki Honma, +2 authors Hajime Iizuka
  • Published in
    Clinical and experimental…
    2011
  • Medicine, Biology
  • BACKGROUND Distinguishing keratoacanthoma (KA) from well-differentiated squamous cell carcinoma (SCC) is sometimes difficult. Recent evidence indicates that the nuclear factor kappa B p50 subunit (p50) and cortactin might be useful to distinguish between these two conditions. AIM To verify whether p50 and cortactin are useful differentiation markers to distinguish between subungual KA and well-differentiated SCC. METHODS Immunohistochemistry using p50, cortactin and Ki-67 was performed on… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Figures, Tables, and Topics from this paper.

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 21 REFERENCES

    The two-faced NF-kappaB in the skin.

    Links between alpha-catenin, NF-kappaB, and squamous cell carcinoma in skin.